Gut Microbiome and Cardiovascular Diseases
AbstractRecent evidence has suggested that the gut microbiome is involved in human health and diseases, such as inflammatory bowel disease, liver cirrhosis, rheumatoid arthritis, and type 2 diabetes. Cardiovascular diseases, which are associated with high morbidity and mortality across the world, are no exception. Increasing evidence has suggested a strong relationship between the gut microbiome and the progression of cardiovascular diseases. We first reported such a relationship with coronary artery disease two years ago. Next-generation sequencing techniques, together with bioinformatics technology, constantly and dramatically expand our knowledge of the complex human gut bacterial ecosystem and reveal the exact role of this bacterial ecosystem in cardiovascular diseases via the functional analysis of the gut microbiome. Such knowledge may pave the way for the development of further diagnostics and therapeutics for prevention and management of cardiovascular diseases. The aim of the current review is to highlight the relationship between the gut microbiome and their metabolites, and the development of cardiovascular diseases by fostering an understanding of recent studies. View Full-Text
Share & Cite This Article
Yoshida, N.; Yamashita, T.; Hirata, K.-I. Gut Microbiome and Cardiovascular Diseases. Diseases 2018, 6, 56.
Yoshida N, Yamashita T, Hirata K-I. Gut Microbiome and Cardiovascular Diseases. Diseases. 2018; 6(3):56.Chicago/Turabian Style
Yoshida, Naofumi; Yamashita, Tomoya; Hirata, Ken-ichi. 2018. "Gut Microbiome and Cardiovascular Diseases." Diseases 6, no. 3: 56.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.